olaquindox has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chen, Q; Jin, X; Tang, S; Xiao, X; Zhang, T; Zou, J | 1 |
| Jin, X; Liu, FY; Sun, CD; Tang, SS; Xiao, XL; Zhang, CM; Zhang, S; Zhang, T; Zhao, WX | 1 |
2 other study(ies) available for olaquindox and cytochrome c-t
| Article | Year |
|---|---|
Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Caspases; Cell Cycle; Cytochromes c; DNA Damage; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Mitochondria, Liver; Poly(ADP-ribose) Polymerases; Polymerase Chain Reaction; Quinoxalines; Tumor Suppressor Protein p53 | 2011 |
c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochromes c; Growth Substances; Humans; Proto-Oncogene Proteins c-myc; Quinoxalines; Reactive Oxygen Species; RNA Interference; Transcription, Genetic; Up-Regulation | 2011 |